Is a complete OGN research report available?

No complete published report is available for Organon & Co. (OGN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

OGN Stock Analysis, Forecast & Valuation

Market cap	3.6B
Revenue (ttm)	6.2B
Net income (ttm)	246M
EPS (ttm)	$0.94
Shares out	262.6M
P/E (trailing)	14.4x
P/E (forward)	3.7x
Dividend	$0.08 (0.59%)
Volume	2,600,165

Beta	1.54

Price target	$11.3	-16.9%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All OGN indicators

Market & fundamental data

Available fields

271

Groups with data

Currency

USD

Showing 271 of 271 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001821825
Company name	Organon & Co.
Country	United States
Country code	US
Cusip	68622V106
Employees	10,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$11B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - General
Industry PE	28.42
Industry PE Fwd	19.55
Isin	US68622V1061
Last refreshed	2026-07-30
Market cap	$3.6B
Market cap category	Mid-Cap
Price	$13.54
Price currency	USD
Rev Per Employee	616,300x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	OGN
Website	https://www.organon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.92%
EV Earnings	44.75x
EV Sales Forward	1.79x
EV/EBIT	9.77x
EV/EBITDA	7.39x
EV/FCF	16.12x
EV/Sales	1.79x
FCF yield	19.21%
Forward P/E	3.71x
P/B ratio	3.94x
P/E ratio	14.37x
P/S ratio	0.58x
PE Ratio3 Y	5.58x
PE Ratio5 Y	5.94x
PEG ratio	1.11x
PS Forward	0.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.29%
EBITDA Margin	24.18%
FCF margin	11.08%
Gross margin	53.84%
Gross Profit	$3.3B
Gross Profit Growth	-8.04%
Gross Profit Growth Q	-7.06%
Gross Profit Growth3 Y	-4.76%
Gross Profit Growth5 Y	-4.08%
Net Income	$246M
Net Income Growth	-67.2%
Net Income Growth Q	67.82%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-30.91%
Net Income Growth5 Y	-33.25%
Pretax Margin	8.71%
Profit Margin	3.99%
Profit Per Employee	$24,600
Profitable Quarters	$1
Profitable Years	8
ROA	5.89
Roa5y	8.46
ROCE	10.74
ROE	34.05
ROIC	6.51
Roic5y	15.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	37.04%
Cagr3y	-11.5%
Cagr5y	-10.99%
Div CAGR3	-58.51%
EPS Growth	-67.25
EPS Growth Q	66.67
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-31.41
EPS Growth5 Y	-33.63
FCF Growth	-12.1%
FCF Growth Q	337.21%
FCF Growth3 Y	2.19%
FCF Growth5 Y	-24.43%
OCF Growth	-9.38%
OCF Growth Q	200%
OCF Growth3 Y	0.04%
OCF Growth5 Y	-22.42%
Revenue Growth	-2.08x
Revenue Growth Q	-3.5x
Revenue Growth Years	0x
Revenue Growth3 Y	0.1x
Revenue Growth5 Y	-0.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.47
Assets	$13B
Cash	$1.1B
Current Assets	$4.9B
Current Liabilities	$2.5B
Debt	$8.6B
Debt EBITDA	$5.75
Debt Equity	$9.49
Debt FCF	$12.55
Equity	$903M
Interest Coverage	2.3
Liabilities	$12.1B
Long Term Assets	$8.1B
Long Term Liabilities	$9.6B
Net Cash	$-7.5B
Net Cash By Market Cap	$-210
Net Debt EBITDA	$5
Net Debt Equity	$8.25
Net Debt FCF	$10.91
Tangible Book Value	$-4.3B
Tangible Book Value Per Share	$-16.56
WACC	5.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.97
Inventory Turnover	2.08
Net Working Capital	$1.3B
Quick ratio	1
Working Capital	$2.4B
Working Capital Turnover	$2.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.55%
Dividend Growth	-90.7%
Dividend Growth Years	0%
Dividend per share	$0.08
Dividend Years	6
Dividend Yield	0.59%
Ex Div Date	2026-05-11
Last Dividend	$0.02
Payout Frequency	Quarterly
Payout Ratio	8.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	37.01%
200-day SMA	9.51
3Y total return	-30.69%
50-day SMA	13.46
50-day SMA vs 200-day SMA	50over200
5Y total return	-44.14%
All Time High	39.48
All Time High Change	-65.7%
All Time High Date	2022-03-02
All Time Low	5.69
All Time Low Change	137.96%
All Time Low Date	2026-03-30
ATR	0.05
Beta	1.54
Beta1y	2.49
Beta2y	0.96
Ch YTD	88.84
High	13.56
High52	13.6
High52 Date	2026-07-01
High52ch	-0.44%
Low	13.52
Low52	5.69
Low52 Date	2026-03-30
Low52ch	137.96%
Ma50ch	0.59%
Price vs 200-day SMA	42.39%
RSI	61.35
RSI Monthly	50.67
RSI Weekly	70.47
Sharpe ratio	0.73x
Sortino ratio	1.42
Total Return	0.04%
Tr YTD	89.59
Tr1m	0.3%
Tr1w	0.15%
Tr3m	1.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	5
Analyst Price Target Top	$11.33
Analyst Ratings	Hold
Analyst Ratings Top	Sell
Earnings EPS Estimate	$1.03
Earnings EPS Estimate Growth	3
Earnings Revenue Estimate	1,552,939,488x
Earnings Revenue Estimate Growth	-2.58x
Operating Income	$1.2B
Operating Income Growth	-13.06
Operating Income Growth Q	-18.26
Operating Income Growth3 Y	-7.78
Operating Income Growth5 Y	-12.72
Operating margin	19.99
Price target	$11.25
Price Target Change	$-16.91
Price Target Change Top	$-16.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	261,078,056%
Float Percent	99.42%
Net Borrowing	-487,000,000
Shares Insiders	0.5%
Shares Institutions	77.1%
Shares Out	262,600,862
Shares Qo Q	1.05%
Shares Yo Y	0.55%
Short Float	6.22%
Short Ratio	6.52
Short Shares	6.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$611M
Adjusted OCF	778,000,000
Average Volume	2,661,239.5x
Bv Per Share	3.44
CAPEX	$-167M
Ch1m	0.3
Ch1w	0.15
Ch1y	35.81
Ch3m	1.65
Ch3y	-38.95
Ch5y	-54.47
Ch6m	52.31
Change	0.15%
Change From Open	0.15
Close	13.52
Days Gap	0
Depreciation Amortization	363,000,000
Dollar Volume	35,206,234.1
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$1.1B
EBITDA	$1.5B
EPS	$0.94
F Score	6
FCF	$683M
FCF EV Yield	6.2x
FCF Per Share	$2.6
Financing CF	-524,000,000
Fiscal Year End	December
Founded	1,923
Goodwill	4,153,000,000
Graham Number	8.53855
Graham Upside	-36.94
Income Tax	$291M
Investing CF	168,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Lynch Fair Value	$4.71
Lynch Upside	-65.2
Ma150	10.14
Ma150ch	33.58%
Ma20	13.52
Ma20ch	0.18%
Net CF	569,000,000
Next Earnings Date	2026-08-11
Open	13.52
Optionable	Yes
P FCF Ratio	5.21
P FCF Ratio SBC	5.82
P OCF Ratio	4.18
P OCF Ratio SBC	4.57
Payment Date	2026-06-11
Position In Range	50
Post Close	13.54
Postmarket Change Percent	-0.15
Postmarket Price	$13.52
Ppne	1,279,000,000
Price Date	2026-07-29
Price EBITDA	$2.39
Relative Volume	0.98x
Revenue	6,163,000,000x
SBC By Revenue	1.17x
Share Based Comp	72,000,000
Tax By Revenue	4.72x
Tax Rate	54.19%
Tr6m	52.91%
Us State	New Jersey
Volume	2,600,165
Z Score	1.26

Organon & Co. (OGN)

Coverage state: Market snapshot only — no published research

Generate the first OGN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · OGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on OGN

Frequently asked questions